Research, perspectives, and practical insights on performance, recovery, and longevity.
Editor's Pick
After multiple knee injuries, surgeries, and setbacks, I've learned that physical recovery and trusting your body again aren't always the same thing.
Read Article
It started with a question in a Facebook peptide group: "Everyone using Chinese manufactured Peptides?" Sixty-eight comments later, the thread had split into two camps — "it's all from China, they're lying if they say otherwise" versus "not everything is Chinese, my US seller makes it here."
Layering specific cell-signaling peptides can maximize their clinical efficacy, but what exact mechanics make a protocol truly synergistic?
Entrepreneur Sean Rakidzich rebuilt his health after workaholism and alcohol. His story reveals why peptides are attracting attention, and where evidence ends and hype begins.
Peptide supply chains may face added pressure this fall as China’s late-September and October holidays overlap with increased FDA scrutiny of GLP-1 APIs and tighter customs enforcement. Here’s what’s changing—and why quality and traceability matter more when supply gets tight.
An FDA panel is discussing easing regulations on certain peptides to meet rising demand for unapproved therapies.
2 matching articles
The Rebuild
For athletes and high performers building long-term health.
Sign up for The Rebuild
Educational emails on performance, recovery, and longevity.
Join the list for future issues of The Rebuild. Unsubscribe anytime. See our privacy policy.
Educational content only. Not medical advice.
